Neuroprotective role of dexpanthenol and butafosfan-vitamin b12 against brain damage induced by circadian rhythm disorder

This study investigates the neuroprotective effects of dexpanthenol (DEX) and butafosfan-vitmain B12 combination (BUT) in a circadian rhythm disorder (CRD)- induced brain damage model in mice. Control, CRD, DEX, BUT, and BUT + DEX groups were subjected to a 19-day experimental period during which CR...

Full description

Saved in:
Bibliographic Details
Main Authors: Simge GARLI, Özlem ÖZMEN, Şerife TAŞAN
Format: Article
Language:English
Published: Kafkas University, Faculty of Veterinary Medicine 2025-07-01
Series:Kafkas Universitesi Veteriner Fakültesi Dergisi
Subjects:
Online Access:https://vetdergikafkas.org/pdf.php?id=3207
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849234786444378112
author Simge GARLI
Özlem ÖZMEN
Şerife TAŞAN
author_facet Simge GARLI
Özlem ÖZMEN
Şerife TAŞAN
author_sort Simge GARLI
collection DOAJ
description This study investigates the neuroprotective effects of dexpanthenol (DEX) and butafosfan-vitmain B12 combination (BUT) in a circadian rhythm disorder (CRD)- induced brain damage model in mice. Control, CRD, DEX, BUT, and BUT + DEX groups were subjected to a 19-day experimental period during which CRD was induced by repeated phase shifts in the light/dark cycle. The CRD group experienced circadian rhythm disorder, while the DEX and BUT groups received intraperitoneal DEX (1000 mg/kg/day) and subcutaneous BUT (200 mg/kg/day) treatments, respectively, for the same duration. Serum cortisol and creatine kinase (CK) levels were measured using ELISA to assess stress and tissue damage. Brain tissues were evaluated histopathologically using hematoxylin and eosin staining, and immunohistochemically for brain-derived neurotrophic factor (BDNF) and glial fibrillary acidic protein (GFAP) expression using specific monoclonal antibodies. CRD significantly increased serum cortisol and CK levels compared to the control group (P<0.001). Both DEX and BUT treatments reduced these elevations, with the combination therapy showing the most pronounced effect (P<0.001). Histopathological examination revealed reduced neuronal degeneration, hyperemia, and hemorrhage in the treatment groups compared to the CRD group. Immunohistochemical analysis showed significantly increased BDNF and GFAP expression in the BUT + DEX group (P<0.001). These findings suggest that DEX and BUT, particularly in combination, exert neuroprotective effects against CRD-induced brain injury by modulating oxidative stress, inflammation, and neurotrophic signaling pathways.
format Article
id doaj-art-9bf3883d8ab846c38e314fc8f5e60e86
institution Kabale University
issn 1309-2251
language English
publishDate 2025-07-01
publisher Kafkas University, Faculty of Veterinary Medicine
record_format Article
series Kafkas Universitesi Veteriner Fakültesi Dergisi
spelling doaj-art-9bf3883d8ab846c38e314fc8f5e60e862025-08-20T04:03:01ZengKafkas University, Faculty of Veterinary MedicineKafkas Universitesi Veteriner Fakültesi Dergisi1309-22512025-07-0131455756410.9775/kvfd.2025.343333207Neuroprotective role of dexpanthenol and butafosfan-vitamin b12 against brain damage induced by circadian rhythm disorderSimge GARLI0Özlem ÖZMEN1Şerife TAŞAN2Burdur Mehmet Akif Ersoy University, Faculty of Veterinary Medicine, Laboratory Animals Production and Experimental Research Center, TR-15030 Burdur - TÜRKİYEBurdur Mehmet Akif Ersoy University, Faculty of Veterinary Medicine, Department of Pathology, TR-15030 Burdur - TÜRKİYEBurdur Mehmet Akif Ersoy University, Faculty of Veterinary Medicine, Department of Pathology, TR-15030 Burdur - TÜRKİYEThis study investigates the neuroprotective effects of dexpanthenol (DEX) and butafosfan-vitmain B12 combination (BUT) in a circadian rhythm disorder (CRD)- induced brain damage model in mice. Control, CRD, DEX, BUT, and BUT + DEX groups were subjected to a 19-day experimental period during which CRD was induced by repeated phase shifts in the light/dark cycle. The CRD group experienced circadian rhythm disorder, while the DEX and BUT groups received intraperitoneal DEX (1000 mg/kg/day) and subcutaneous BUT (200 mg/kg/day) treatments, respectively, for the same duration. Serum cortisol and creatine kinase (CK) levels were measured using ELISA to assess stress and tissue damage. Brain tissues were evaluated histopathologically using hematoxylin and eosin staining, and immunohistochemically for brain-derived neurotrophic factor (BDNF) and glial fibrillary acidic protein (GFAP) expression using specific monoclonal antibodies. CRD significantly increased serum cortisol and CK levels compared to the control group (P<0.001). Both DEX and BUT treatments reduced these elevations, with the combination therapy showing the most pronounced effect (P<0.001). Histopathological examination revealed reduced neuronal degeneration, hyperemia, and hemorrhage in the treatment groups compared to the CRD group. Immunohistochemical analysis showed significantly increased BDNF and GFAP expression in the BUT + DEX group (P<0.001). These findings suggest that DEX and BUT, particularly in combination, exert neuroprotective effects against CRD-induced brain injury by modulating oxidative stress, inflammation, and neurotrophic signaling pathways.https://vetdergikafkas.org/pdf.php?id=3207butafosfancircadian rhythmdexpanthenolneuroprotectivevitamin b12
spellingShingle Simge GARLI
Özlem ÖZMEN
Şerife TAŞAN
Neuroprotective role of dexpanthenol and butafosfan-vitamin b12 against brain damage induced by circadian rhythm disorder
Kafkas Universitesi Veteriner Fakültesi Dergisi
butafosfan
circadian rhythm
dexpanthenol
neuroprotective
vitamin b12
title Neuroprotective role of dexpanthenol and butafosfan-vitamin b12 against brain damage induced by circadian rhythm disorder
title_full Neuroprotective role of dexpanthenol and butafosfan-vitamin b12 against brain damage induced by circadian rhythm disorder
title_fullStr Neuroprotective role of dexpanthenol and butafosfan-vitamin b12 against brain damage induced by circadian rhythm disorder
title_full_unstemmed Neuroprotective role of dexpanthenol and butafosfan-vitamin b12 against brain damage induced by circadian rhythm disorder
title_short Neuroprotective role of dexpanthenol and butafosfan-vitamin b12 against brain damage induced by circadian rhythm disorder
title_sort neuroprotective role of dexpanthenol and butafosfan vitamin b12 against brain damage induced by circadian rhythm disorder
topic butafosfan
circadian rhythm
dexpanthenol
neuroprotective
vitamin b12
url https://vetdergikafkas.org/pdf.php?id=3207
work_keys_str_mv AT simgegarli neuroprotectiveroleofdexpanthenolandbutafosfanvitaminb12againstbraindamageinducedbycircadianrhythmdisorder
AT ozlemozmen neuroprotectiveroleofdexpanthenolandbutafosfanvitaminb12againstbraindamageinducedbycircadianrhythmdisorder
AT serifetasan neuroprotectiveroleofdexpanthenolandbutafosfanvitaminb12againstbraindamageinducedbycircadianrhythmdisorder